These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21360474)

  • 1. LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients.
    Bowden RG; Wilson RL; Beaujean AA
    J Nephrol; 2011; 24(6):771-7. PubMed ID: 21360474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of lipid measures and risk stratification among end-stage renal disease patients.
    Bowden RG; Hebert S; Wilson R; Gentile M; Lanning BA
    J Nephrol; 2007; 20(2):212-8. PubMed ID: 17514626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse epidemiology of lipid-death associations in a cohort of end-stage renal disease patients.
    Bowden RG; La Bounty P; Shelmadine B; Beaujean AA; Wilson RL; Hebert S
    Nephron Clin Pract; 2011; 119(3):c214-9. PubMed ID: 21832847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study.
    Shelmadine B; Bowden RG; Wilson RL; Beavers D; Hartman J
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):385-9. PubMed ID: 19819789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
    Boizel R; Benhamou PY; Lardy B; Laporte F; Foulon T; Halimi S
    Diabetes Care; 2000 Nov; 23(11):1679-85. PubMed ID: 11092292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL molecular size as risk factor in coronary artery disease.
    Kozma L; Fodor J; Chockalingam A; Sussex B
    Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of non-high-density lipoprotein cholesterol and calculated intermediate-density lipoprotein to identify nontraditional lipoprotein subclass risk factors in dialysis patients.
    Belani SS; Goldberg AC; Coyne DW
    Am J Kidney Dis; 2004 Feb; 43(2):320-9. PubMed ID: 14750098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of LDL Particle Size Using Lipid Indices: A Population-Based Study of 1578 Schoolchildren.
    Watabe Y; Arisaka O; Miyake N; Ichikawa G; Koyama S; Shimura N
    Metab Syndr Relat Disord; 2015 Dec; 13(10):465-9. PubMed ID: 26469303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
    Farish E; Spowart K; Barnes JF; Fletcher CD; Calder A; Brown A; Hart DM
    Atherosclerosis; 1996 Sep; 126(1):77-84. PubMed ID: 8879436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High density lipoprotein (HDL) particle composition in patients with end stage renal failure (ESRF) on chronic dialysis.
    Lee P; O'Neal D; Murphy B; Best J
    Aust N Z J Med; 1997 Jun; 27(3):285-93. PubMed ID: 9227812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis.
    O'Neal D; Lee P; Murphy B; Best J
    Am J Kidney Dis; 1996 Jan; 27(1):84-91. PubMed ID: 8546142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?
    Gluba-Brzózka A; Franczyk B; Banach M; Rysz-Górzyńska M
    Int Urol Nephrol; 2017 Jan; 49(1):155-164. PubMed ID: 27942970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
    Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
    Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
    Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
    Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.